Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways
Author:
Affiliation:
1. Molecular Oncology Laboratory of Cancer Research Institute, The First Affiliated Hospital of China Medical University, Shenyang, China
Funder
National Natural Science Foundation of China
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Link
http://academic.oup.com/carcin/article-pdf/39/5/700/24774141/bgy039.pdf
Reference33 articles.
1. A time to kill: targeting apoptosis in cancer;Koff;Int. J. Mol. Sci,2015
2. Broad targeting of resistance to apoptosis in cancer;Mohammad;Semin. Cancer Biol,2015
3. Necroptosis: an emerging form of programmed cell death;Wu;Crit. Rev. Oncol. Hematol,2012
4. Programmed necrosis and necroptosis signalling;Feoktistova;FEBS J,2015
5. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation;Jouan-Lanhouet;Cell Death Differ,2012
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells;Journal of Liposome Research;2024-01-25
2. Transcriptomic Insights into the Antitumor Mechanism of Bufalin in Hepatocellular Carcinoma Cell HepG2;2023-10-30
3. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives;Frontiers in Pharmacology;2023-10-04
4. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis;Molecules;2023-09-23
5. Bufalin reduces myocardial infarction‐induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL‐1β signalling pathway;Clinical and Experimental Pharmacology and Physiology;2023-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3